Rina Mehmeti

Rina Mehmeti

Auto-generated profile, based on publicly available information

Rina Mehmeti

Institute of Tissue Medicine and Pathology, University of Bern

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
EBElias Baumann
Elias Baumann
JCJosé F Carreño-Martinez
José F Carreño-Martinez
AFAna Leni Frei
Ana Leni Frei
JGJavier Garcia-Baroja
Javier Garcia-Baroja
MGMauro Gwerder
Mauro Gwerder
IZInti Zlobec
Inti Zlobec
BACKGROUND Pathology reporting of colorectal cancer (CRC) follows the International Collaboration on Cancer Reporting (ICCR) guidelines which define a set of 25 elements (such as tumor grade, TNM stage and microsatellite instability) to be assessed for diagnosis. With the aim to further develop the CRC diagnostic routine, multiple computational tools have been developed in the last ten years. Despite the excellent sensitivity and potential advantages, including reduced inter-observer variability, many tools do not reach clinical deployment. This suggests that there are critical challenges to address when developing these algorithms given the aim to reliably and automatically assess ICCR elements. METHODS To summarize existing efforts in deep- and machine learning for ICCR CRC elements and highlight existing gaps between development and clinical deployment, this systematic review collected studies on computational tools for colorectal cancer histopathology analysis published between 2015 and 2024. RESULTS In total, 4863 studies were retrieved for the analysis, of which 66 remained after screening. Most of the reviewed studies focus on a subset of just three ICCR elements, namely mismatch repair status, BRAFV600E mutation testing, and lymph node status. Notably, many of the studies did not include clinically relevant and validated results, which puts into question their reliability for routine diagnosis. CONCLUSION These results show the wide gap between research and clinical practice in pathology with the example of CRC diagnosis. There is an unmet need for publicly available datasets addressing a variety of topics, and a stronger focus on clinically important tasks. This review is critical to help the community align their contributions in computation pathology with the clinic and ultimately increase the translational potential of the developed tools.

21 January 2025 in European Journal of Histochemistry
Verified
Journal Article
Open access
YMYasmeen H. Mady
Yasmeen H. Mady
CKCarmen G. Kalbermatter
Carmen G. Kalbermatter
MKMaarij Khan
Maarij Khan
ASAnna M. Schläfli
Anna M. Schläfli
RMRina Mehmeti
Rina Mehmeti
Mario P. TschanMario P. Tschan
Mario P. Tschan
Accurate differentiation of homologous proteins that share high sequence identity remains a significant challenge in biomedical research, as conventional antibodies often lack sufficient specificity, leading to potential misinterpretations. This issue is particularly evident in the study of hexokinases, a family of isoenzymes that catalyze the first step of glycolysis by phosphorylating glucose. Beyond their canonical metabolic roles, hexokinases play critical non-glycolytic functions, especially in cancer biology. However, their unique tissue distributions and context-dependent roles are often obscured by the overlapping specificities of commercially available antibodies, which can produce misleading results. In this study, we rigorously evaluated a panel of antibodies targeting hexokinase isoenzyme 3 (HK3), highlighting the widespread issue of cross-reactivity and insufficient validation. Through this process, we identified and validated a highly specific antibody for HK3, demonstrating its reliability in western blot and immunohistochemistry applications. Using this validated tool, we reveal the distinct localization of HK3 in myeloid cell populations, providing new insights into its potential functional roles in these cells. This work addresses a critical gap in antibody specificity and establishes HK3 as a uniquely expressed gene in myeloid and immune cells and is absent in other cell types under basal conditions. Providing a foundation for future investigations into its context-dependent functions.